[5] These improvements likely result from multiple mechanisms working together, including enhanced collagen production, improved tissue repair, and reduced inflammatory stress
This shift reflects a deeper transformation
Doctors can treat diabetes or metabolic syndrome by giving people that hormone as a drug, but the real root problem isnt a hormone deficiency
In the SUSTAIN-6 study, which compared subcutaneous semaglutide to placebo, DR complications occurred in 3% of semaglutide and 1.8% of placebo subjects
Semaglutide boosts this process by making the body release more insulin when blood sugar goes up, which is key to keeping glucose levels in check
Multiple Phase 1-2 trials are evaluating safety and efficacy, with promising results for reducing ovarian hyperstimulation syndrome (OHSS) in high-risk patients